On July 28, 2016, the Board of Directors of Agile Therapeutics, Inc. appointed Seth H.Z. Fischer, as a director and as a member of the Board's Compensation and Nominating and Corporate Governance Committees. Mr. Fischer will serve as a Class II member of the Board. The terms of Class II directors expire at the 2019 Annual Meeting of Shareholders. Mr. Fischer has more than three decades of healthcare experience in the pharmaceutical and medical device industry. Since 2013, he has served as Chief Executive Officer and a Director of Vivus, Inc. Mr. Fischer also serves as a member of the Board of Directors of BioSig Technologies, Inc. Also on July 28, 2016, Karen Hong Ph.D., a director of the company, notified the Board that she was resigning from the Board, effective immediately, so that she may devote her full time and efforts to her other commitments. In connection with Dr. Hong's resignation, the Board appointed Abhijeet Lele, a current director of the company, to serve as the chair of the Board's Nominating and Corporate Governance Committee in place of Dr. Hong.
Agile Therapeutics, Inc. is a women's healthcare company, which is engaged in fulfilling the unmet health needs of women. Its product and product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. Its initial product, Twirla, (levonorgestrel and ethinyl estradiol), a transdermal system, is a non-daily prescription contraceptive. Twirla is based on its proprietary transdermal patch technology, called Skinfusion, which is designed to allow drug delivery through the skin. Twirla (levonorgestrel and ethinyl estradiol) transdermal system is a once-weekly combined hormonal contraceptive (CHC) patch that contains the active ingredients levonorgestrel (LNG), a type of progestin, and ethinyl estradiol (EE), a type of estrogen. Its potential product pipeline consists of two types of product candidates: a progestin-only (P-only) contraceptive patch and potential Twirla line extensions.
AGILE THERAPEUTICS, INC. 
